Bayer integrates R&D activities
Bayer CropScience is integrating its research and development activities into one global organisation. The company is also placing increasing emphasis on the seed and trait BioScience business unit, and on new growth areas in agrochemical research, such as plant health and stress tolerance. The company plans to double its annual R&D expenditure in BioScience by 2015 from the level of €200 million in 2010 ($262 million at the current rate - Agrow No 625, pp 8-9). Bayer CropScience’s annual R&D budget is set to gradually rise by about 20% over the same period, to more than €850 million ($1,113 million). The new organisation is to be led by Dr David Nicholson (see this issue).